Journal article
Advances in Biomarkers for Detection, Surveillance, and Prognosis of Bladder Cancer
Clinical genitourinary cancer, Vol.19(3), pp.194-198
06/01/2021
DOI: 10.1016/j.clgc.2020.12.003
PMID: 33781702
Abstract
Bladder cancer may present management challenges, as it frequently recurs and can progress when not expeditiously diagnosed and carefully monitored following initial therapy for noninvasive disease. Cystoscopy and cytology have long been the primary tools for the urologist treating bladder cancer. However, as a host of potential biomarkers have been developed, new avenues for noninvasive testing have become available in the detection, surveillance, and prognostic setting. Analysis of urine for mutational signatures at the genetic and epigenetic levels appears promising, but such testing has yet to become widely adopted into clinical practice. Here, we review recent advances in bladder cancer biomarker assays, with particular attention to clinical relevance and potential application.
Details
- Title: Subtitle
- Advances in Biomarkers for Detection, Surveillance, and Prognosis of Bladder Cancer
- Creators
- Grant M. Henning - Washington University in St. LouisNimrod S. Barashi - Washington University in St. LouisZachary L. Smith - Washington University in St. Louis
- Resource Type
- Journal article
- Publication Details
- Clinical genitourinary cancer, Vol.19(3), pp.194-198
- DOI
- 10.1016/j.clgc.2020.12.003
- PMID
- 33781702
- NLM abbreviation
- Clin Genitourin Cancer
- ISSN
- 1558-7673
- eISSN
- 1938-0682
- Publisher
- Cig Media Group, Lp
- Number of pages
- 5
- Language
- English
- Date published
- 06/01/2021
- Academic Unit
- Urology
- Record Identifier
- 9984949179402771
Metrics
1 Record Views